I can't believe I'm writing this, but in the fall of 2025 I will celebrate 20 years of professional communications and marketing experience in the biotechnology, life science and healthcare industries.
Throughout my career, I have been the voice behind nearly a dozen executives, providing counsel and support for their thought leadership and presentation needs—from slide decks to talking points to speechwriting and beyond. I have served as a corporate spokesperson for analysts, advocates and media, securing both trade and top-tier media coverage for numerous corporations.
I have designed events for 1,000 employees and launched social media channels and intranets for multi-national corporations. Further, I have developed communications strategies for celebrity awareness campaigns and been the strategic lead for numerous crisis management campaigns across product recalls, stock price fluctuations, merger & acquisitions and executive transitions, to name a few.
While all of this is exciting, nothing inspires me more than the adventure that lies ahead.
Have a question? Pop it in the chat!
Codexis’ ECO Synthesis™ technology is a proprietary new synthesis platform that is being developed for manufacturing siRNA therapeutics at scale. By replacing crucial chemical processes with enzymatic methods, ECO Synthesis™ technology is envisioned to address the scalability and significant utilization of hazardous waste in oligonucleotide manufacturing.
Check out this seven-minute, mini documentary from November 2023 introducing viewers to Codexis and it's groundbreaking enzymatic synthesis technology.
In September 2023, Codexis unveiled a new visual identity with enhanced visual elements, purpose statement and company values. This one-minute teaser video unveiled the new visual identity for employees and other stakeholders.
As developers of the world's leading siRNA manufacturing platform, Codexis needed to provide clear & concise background information to investors on what this new technology was and how it worked. This short overview video on RNAi therapeutics did the trick!
Sierra Oncology needed a corporate overview video to play in booths at medical and market access meetings to introduce the company and provide information on myelofibrosis. A 90 second video was developed to meet these needs.
On DATE, Sierra Oncology announced stellar Phase 3 pivotal data on its investigational compound for the potential treatment of myelofibrosis. After a stellar media push, this recap video was developed to share with various stakeholders, including investors, study investigators and the Board.
The best of intentions will get you nowhere without a clear and defined strategy. Be it an annual plan, a data milestone or a brand launch, I've developed numerous communications strategies for my companies and clients.
I have launched six products thus far in my career: Velcade, Jevtana, Zaltrap, Aptiom, Varuby and Zejula. Additionally, I've led strategic communications for multiple Phase 3 data read outs and completed pre-launch activities for Adcetris and Oojjaara.
I have launched multiple corporate rebrands in my career, including for Sunovion, Tesaro, Sierra Oncology and Codexis.
Over twenty years, I have navigated countless issues and crises in a calm and thoughtful manner. This includes product recalls, 80% dips in stock price, a global pandemic, multiple layoffs and C-suite turnover.
I have been the voice behind nearly a dozen C-suite executives, supporting all their presentation and communications needs, and coached on delivery and executive for key thought leadership opportunities.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.